Lampert Mark N

CIK 0001233840

Director10% Owner

Filings

Latest May 18, 2026

Issuers covered

Showing

50 of 59

Page 1

Track record

71 of 111 open-market trades scored (64% price coverage) - 40 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	71	66%	+11.3%	+11.9%	+76.1%	-29.1%
90 days	68	71%	+33.6%	+10.4%	+171.4%	-51.5%
180 days	68	69%	+32.9%	+13.0%	+178.3%	-49.6%
365 days	65	58%	+46.0%	+3.4%	+284.7%	-54.3%

Issuers

Companies where Lampert Mark N has filed

Ticker	Issuer	Filings	Last filed
KYMR	Kymera Therapeutics, Inc.	13	Jul 1, 2025
OLMA	Olema Pharmaceuticals, Inc.	7	Jun 13, 2025
RPTX	Repare Therapeutics Inc.	7	Jan 30, 2026
XOMA	Xoma Corp	6	May 18, 2026
MLTX	Moonlake Immunotherapeutics	5	Apr 2, 2026
CGEM	Cullinan Oncology, Inc.	4	Jan 19, 2023
CTIC	Cti Biopharma Corp	3	Jun 28, 2023
ELDN	Eledon Pharmaceuticals, Inc.	3	Oct 31, 2024
EPIX	Essa Pharma Inc.	2	Oct 14, 2025
RAIN	Rain Oncology Inc.	2	Jan 29, 2024
FDMT	4d Molecular Therapeutics, Inc.	1	Nov 13, 2024
ALLK	Allakos Inc.	1	May 19, 2025
GLYC	Glycomimetics Inc	1	Jun 17, 2025
PIRS	Pieris Pharmaceuticals, Inc.	1	Dec 17, 2024
PNT	Point Biopharma Global Inc.	1	Dec 20, 2023
GPCR	Structure Therapeutics Inc.	1	May 12, 2023
THRD	Third Harmonic Bio, Inc.	1	Oct 31, 2024

All filings

59 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 18, 2026	XOMAXoma Corp	CConversion	2,313,000	$4.03	$9,321,390
Apr 2, 2026	MLTXMoonlake Immunotherapeutics	SSale	1,932,354	$16.79	$32,444,224
Jan 30, 2026	RPTXRepare Therapeutics Inc.	UTender	5,309,432	-	-
Oct 14, 2025	EPIXEssa Pharma Inc.	UTender	6,194,145	-	-
Aug 7, 2025	EPIXEssa Pharma Inc.	SSale	79	$1.8779	$148
Jul 1, 2025	KYMRKymera Therapeutics, Inc.	PPurchase	142,604	$44.00	$6,274,576
Jun 17, 2025	GLYCGlycomimetics Inc	JOther	657,308	-	-
Jun 13, 2025	OLMAOlema Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 9, 2025	MLTXMoonlake Immunotherapeutics	Holdings only	-	-	-
May 20, 2025	XOMAXoma Corp	SSale	265,316	$27.10	$7,190,064
May 19, 2025	ALLKAllakos Inc.	DDisposition	8,679,726	-	-
Jan 28, 2025	XOMAXoma Corp	SSale	339,679	$26.10	$8,865,622
Jan 14, 2025	OLMAOlema Pharmaceuticals, Inc.	DDisposition	235,450	-	-
Dec 17, 2024	PIRSPieris Pharmaceuticals, Inc.	JOther	234,323	-	-
Dec 4, 2024	OLMAOlema Pharmaceuticals, Inc.	DDisposition	1,797,527	-	-
Nov 13, 2024	FDMT4d Molecular Therapeutics, Inc.	JOther	3,062,000	-	-
Oct 31, 2024	ELDNEledon Pharmaceuticals, Inc.	Holdings only	-	-	-
Oct 31, 2024	THRDThird Harmonic Bio, Inc.	SSale	538,420	$14.30	$7,699,406
Oct 8, 2024	MLTXMoonlake Immunotherapeutics	SSale	1,030,589	$50.0016	$51,531,099
Aug 22, 2024	KYMRKymera Therapeutics, Inc.	Holdings only	-	-	-
Jun 28, 2024	KYMRKymera Therapeutics, Inc.	Holdings only	-	-	-
Jun 18, 2024	OLMAOlema Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 10, 2024	MLTXMoonlake Immunotherapeutics	Holdings only	-	-	-
May 13, 2024	ELDNEledon Pharmaceuticals, Inc.	PPurchase	1,031,385	-	-
Jan 29, 2024	RAINRain Oncology Inc.	UTender	1,734,960	-	-
Jan 9, 2024	KYMRKymera Therapeutics, Inc.	Holdings only	-	-	-
Dec 20, 2023	PNTPoint Biopharma Global Inc.	SSale	8,974,245	$12.45	$111,729,350
Nov 17, 2023	RPTXRepare Therapeutics Inc.	PPurchase	493,337	$4.9999	$2,466,636
Nov 6, 2023	KYMRKymera Therapeutics, Inc.	PPurchase	132,016	$11.6444	$1,537,247
Nov 3, 2023	RPTXRepare Therapeutics Inc.	PPurchase	492,251	$3.60	$1,772,104
Sep 14, 2023	OLMAOlema Pharmaceuticals, Inc.	PPurchase	775,278	$9.84	$7,628,736
Jun 28, 2023	CTICCti Biopharma Corp	UTender	3,989,130	$9.10	$36,301,083
Jun 21, 2023	OLMAOlema Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 20, 2023	KYMRKymera Therapeutics, Inc.	Holdings only	-	-	-
Jun 12, 2023	MLTXMoonlake Immunotherapeutics	Holdings only	-	-	-
May 19, 2023	XOMAXoma Corp	Holdings only	-	-	-
May 12, 2023	GPCRStructure Therapeutics Inc.	JOther	4,018,253	-	-
May 9, 2023	ELDNEledon Pharmaceuticals, Inc.	PPurchase	1,055,445	-	-
Apr 7, 2023	CTICCti Biopharma Corp	Holdings only	-	-	-
Jan 19, 2023	CGEMCullinan Oncology, Inc.	JOther	3,500,000	-	-
Jan 13, 2023	KYMRKymera Therapeutics, Inc.	PPurchase	15,912	$31.2426	$497,132
Jan 9, 2023	XOMAXoma Corp	PPurchase	15,670	$18.3852	$288,096
Jun 17, 2022	KYMRKymera Therapeutics, Inc.	Holdings only	-	-	-
Jun 15, 2022	RPTXRepare Therapeutics Inc.	PPurchase	74,666	$12.73	$950,498
Jun 14, 2022	OLMAOlema Pharmaceuticals, Inc.	PPurchase	158,583	$4.0345	$639,803
Jun 6, 2022	RPTXRepare Therapeutics Inc.	PPurchase	660,654	$11.6824	$7,718,024
Jun 3, 2022	CGEMCullinan Oncology, Inc.	PPurchase	405,641	$10.9994	$4,461,808
May 31, 2022	KYMRKymera Therapeutics, Inc.	PPurchase	123,043	$14.2106	$1,748,515
May 24, 2022	KYMRKymera Therapeutics, Inc.	PPurchase	5,883	$13.9994	$82,358
May 20, 2022	RPTXRepare Therapeutics Inc.	PPurchase	224,388	$8.50	$1,907,298

Showing 1-50 of 59

Page 1 of 2Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value